About

Dr. Jiping Wang

Gastrointestinal Cancer Treatment Center, Dana-Farber Cancer Institute
Division of Surgical Oncology, Department of Surgery, Brigham and Women’s Hospital
Assistant Professor of Surgery, Harvard Medical School

Jiping Wang is an Assistant Professor of Surgery at Harvard Medical School and a surgical oncologist at Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Dr. Wang received his MD from the Henan Medical University (China) and his PhD in Biostatistics from the University of Pittsburgh.

After graduating with top 1% of his class from the medical school in 1991, Dr. Wang trained in anesthesiology and practiced anesthesia & critical care in China.

He then came to the US, earned a M.Sc. and PhD. in biostatistics from the University of Pittsburgh, and served as a biostatistician at National Surgical Adjuvant Breast and Bowel Project (NSABP).

In 2004, he became a surgical resident at State University of New York (SUNY) at Buffalo, where he graduated with the honor of “The best resident”. During his surgical training, he was also appointed as assistant professor at Department of Biostatistics at SUNY Buffalo and the statistical consultant at Roswell Park Cancer Institute. He developed a unique statistical course for residents and fellows named “Anatomy of Biostatistics”.

He focused on upper GI cancer during his surgical oncology fellowship training at Massachusetts General Hospital, Dana Farber Cancer Institute and Brigham and Women’s Hospital. Because China accounts for 40-50% of all liver and gastric cancers worldwide, as part of his fellowship training, he visited hospitals in China, such as Beijing Union Hospital, Zhongshan Hospital in Shanghai and Queen Mary Hospital in Hong Kong to enrich his experience in the two cancers, including the surgical skills and perioperative management of the cancers. He initiated the minimal invasive gastric cancer program and developed minimal invasive gastric cancer surgery teaching material at BWH thereafter. As the international committee member of The Society for Surgery of the Alimentary Tract (SSAT), he co-organized its online education series: How I do it: Gastric Cancer and How I do it: Pancreatic Disease.

These unique academic background and training experiences made him a unique surgical oncologist in comprehensive care for surgical cancer patients. Dr. Wang’s clinic focus is minimally invasive cancer surgery for gastrointestinal malignancies including liver cancer, colorectal cancer liver metastasis, pancreatic, gastric, colorectal cancer and neuroendocrine tumors.

Dr. Wang has been involved in cancer research for more than ten years. His research focuses on identification of tumor markers for cancer screening, monitoring treatment effect and prognosis; development of algorithms and/or scoring systems to guide clinical oncology research and practice, and clinical trials for cancer prevention and treatment. His research has received many awards including: American Society of Clinical Oncology (ASCO) Annual Meeting Merit Award (2008, 2010), ASCO Breast Cancer Symposium Merit Award (2007), Seed Grant from American Medical Association (2008) and AstraZeneca Scholar (2002). Dr. Wang served as the committee member for American College of Surgeon and Society for Surgery of Alimentary Tract.